[The use of mildronat in heart failure in patients with chronic ischemic heart disease].
A new native cardioprotector mildronat was used for the treatment of cardiac insufficiency due to ischemic heart disease. It was established that mildronate produced a positive effect on the hemodynamics and gaseous composition of the blood. The patients also showed normalization of the nitrogen metabolism and activity of the membrane-bound erythrocytic enzymes.
Sakharchuk
I I
II
Denisenko
G T
GT
Grushko
V S
VS
Bodaretskaia
O I
OI
Pishchalenko
A N
AN
D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003327:Coronary Disease / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D004341:Drug Evaluation; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D050563:gamma-Butyrobetaine Dioxygenase
D002317:Cardiovascular Agents; D006899:Mixed Function Oxygenases; D050563:gamma-Butyrobetaine Dioxygenase
Primenenie mildronata pri serdechnoĭ nedostatochnosti u bol'nykh khronicheskoĭ ishemicheskoĭ bolezn'iu serdtsa.